Arithmos performs GxP services for the Pharmaceutical industry including Audits, QMS development and Regulatory Inspection preparation and hosting

Qualified Person certifying Investigational Medicinal Products for Clinical Trials

Acceler8 Clinical Research is a Full service Global CRO conducts clinical studies for pharmaceutical, biotechnology, and medical device companies. Our clinical trial development processes facilitate commercial efficiency and cost effectiveness in helping bring clients’ products to market. We are used to working with clients who have to be efficient with their resources. Our team are flexible in working in changing environments and are able to manage your clinical programme from concept, through to marketing application if required. Our success is achieved through recruitment and development of high calibre staff. Customer loyalty is also an important factor in our success. All of our sponsors have awarded us repeat business and/or recommended us to other organisations.Acceler8 Clinical Research is a full service global Clinical CRO with a wide range of therapeutic area expertise and all of our personnel have direct, hands on experience of Clinical Trials and ICH GCP with the ability to provide a real world insight into the role. A8CR have particular expertise in novel products that do not have a classic route to market such as Advanced therapies.

TCTC (ANZ) is a global CRO which is expert in brining healthcare products which do not follow the classic road map for approval to market.

TCTC (Asia) Pte ltd is the latest addition to the TCTC Group family. The new operation based in Singapore will help support our existing clients and allow companies in the region to easily access TCTC's unique offering for Biotech, Pharma and medical device companies.

I am Director at The CNS Company is an international, specialist Clinical Research Organisation (CRO) specialising in neurology, psychiatry and orphan indications

The Clinical Trial Company (USA) Inc is an American corporation that trades from 1900 South Norfolk St, Suite 350, San Mateo CA 94403, United States of America.TCTC (USA) is a full service CRO which specializes in Advanced Therapies and products which do not have a classic route to market.

The Clinical Trial Company (Canada) Ltd is a Canadian corporation that trades from 91 Suite 203, 5th Avenue, Pincourt, J7V 5K8 Montreal, Quebec, Canada.TCTC (Canada) is a full service CRO which specializes in Advanced Therapies and products which do not have a classic route to market. TCTC also has RA, QA and interim resourcing divisions.

The Clinical Trial Company™ (TCTC) believe that our extensive study experience, in particular that relating to practical pharmaceutical development, and our experience with the major regulatory bodies including the EMA and FDA, will bring to you efficiency savings and tangible cost effective benefits. Our approach will be to integrate seamlessly with you in supporting all subcontracted tasks.Formed in 2002, TCTC Group is a privately owned full-service clinical research provider with offices in the UK, Europe, North America and Australia. The group operates as The CLINICAL TRIAL Company Limited, Registered in England and Wales (4372093). TCTC has its registered office at Mere View Barn, Park Lane, Pickmere, Knutsford, Cheshire, WA16 0LG.; United Kingdom. The CLINICAL TRIAL Company also has two sister comanies , A Canadian corporation, which is incorporated under the name of The Clinical Trial Company (Canada) Ltd. The Canadian corporation trades from 91 Suite 203, 5th Avenue, Pincourt, J7V 5K8 Montreal, Quebec, Canada. and a US corporation, The Clinical Trial Company (USA) Inc that trades from 1900 South Norfolk St, Suite 350, San Mateo CA 94403, United States of America.

TCTC were a Clinical CRO focused in the area of Advanced Therapies and Acquired in 2019

Non-Executive Director at KWS BioTest, a cutting edge company which works closely with clients to develop lead compounds as novel treatments for human diseases in the fields of infection, inflammation, immunology, oncology and pain, using validated in vitro and in vivo models.

Responsible for clinical trials of cell therapy products Phase I-Phase III. I also released sterile Investigational Medicinal products for clinical trial as QP (IMP) for intercytex.